Moreover, inhibiting Atox1 delivery to CCS protein by small molecules was effective in killing breast, lung, leukaemia, head, and neck cancer cells in vitro and in a mouse xenograft model, while having only minimal effects on healthy cells (Wang et al., 2015). Here, ATOX1 is linked to malignant tumor of neck.